Atlas Trials

Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype

Clinical trial NCT02135263 · COMPLETED

Trial details

NCT number
NCT02135263
Sponsor
Bispebjerg Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Carboxylesterase 1 (CES1) GenotypeCES1 Activity
Start date
2012-04-01
Primary completion
2014-05-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.